We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Centuri Holdings
CTRI
$2.4B
| $26.9M | 0.03% |
1,067,259
-1,787,805
| -63% | -$40M |
|
552
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.56B
| $26.9M | 0.03% |
415,700
-124,300
| -23% | -$7.81M |
|
553
PUT
Arm
ARM
$286B
| $26.9M | 0.03% |
246,200
+148,100
| +151% | +$21.5M |
|
554
Walmart Inc
WMT
$897B
| $26.9M | 0.03% |
241,434
-1,023,975
| -81% | -$110M |
|
555
PUT
Ulta Beauty
ULTA
$23.6B
| $26.8M | 0.03% |
44,300
+11,500
| +35% | +$6.32M |
|
556
Diamondback Energy
FANG
$55.7B
| $26.7M | 0.03% |
177,467
-279,219
| -61% | -$41.2M |
|
557
Cenovus Energy
CVE
$54.5B
| $26.6M | 0.03% |
1,571,629
-1,007,843
| -39% | -$17.5M |
|
558
PUT
Carvana
CVNA
$81.5B
| $26.5M | 0.03% |
314,000
-165,500
| -35% | -$12.3M |
|
559
Jefferies Financial Group
JEF
$12.8B
| $26.5M | 0.03% |
427,365
-461,175
| -52% | -$26.4M |
|
560
Ormat Technologies
ORA
$6.87B
| $26.5M | 0.03% |
239,726
+181,961
| +315% | +$19.9M |
|
561
Align Technology
ALGN
$12.5B
| $26.2M | 0.03% |
+167,600
| New | +$24M |
|
562
PUT
McDonald's
MCD
$194B
| $26.1M | 0.03% |
85,400
+75,100
| +729% | +$23M |
|
563
PUT
American Airlines Group
AAL
$9.93B
| $26.1M | 0.03% |
1,700,800
-1,947,800
| -53% | -$26.3M |
|
564
Celestica
CLS
$36.2B
| $25.9M | 0.03% |
87,664
-61,612
| -41% | -$18.6M |
|
|
NVO
565
Novo Nordisk
NVO
$211B
| $25.9M | 0.03% |
508,109
+464,129
| +1,055% | +$23.7M |
|
566
HealthEquity
HQY
$8.93B
| $25.8M | 0.03% |
+281,631
| New | +$27M |
|
567
lululemon athletica
LULU
$14.5B
| $25.8M | 0.03% |
124,001
+109,887
| +779% | +$19.9M |
|
568
PUT
Berkshire Hathaway Class B
BRK.B
$1.14T
| $25.6M | 0.03% |
50,900
-19,000
| -27% | -$9.45M |
|
569
PUT
Nike
NKE
$62.5B
| $25.5M | 0.03% |
401,000
+268,000
| +202% | +$17.5M |
|
570
Archrock
AROC
$5.81B
| $25.5M | 0.03% |
980,165
-37,914
| -4% | -$943K |
|
571
Ambarella
AMBA
$3.6B
| $25.5M | 0.03% |
359,899
+29,097
| +9% | +$2.35M |
|
572
Nasdaq
NDAQ
$53.4B
| $25.5M | 0.03% |
262,345
-892,498
| -77% | -$80.3M |
|
573
Matsons
MATX
$6.24B
| $25.5M | 0.03% |
206,036
-61,895
| -23% | -$6.65M |
|
574
PUT
AstraZeneca
AZN
$251B
| $25.3M | 0.03% |
137,550
+91,900
| +201% | +$16.1M |
|
575
CALL
Airbnb
ABNB
$111B
| $25.2M | 0.03% |
185,400
+64,600
| +53% | +$8.04M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.